The Canadian Transfusion Surveillance System: What is it and how can the data be used?

Transfusion and Apheresis Science

Volumn 46, Issue 3, 2012, Pages 329-335

  Ditomasso, Julie ^a   Liu, Yang ^b   Heddle, Nancy M ^b  

^a HAMILTON REGIONAL LABORATORY MEDICINE PROGRAM   (Canada)

^b MCMASTER UNIVERSITY   (Canada)

Author keywords

[No Author keywords available]

Indexed keywords

PLASMA PROTEIN;

BACTERIUM CONTAMINATION; BLOOD SAFETY; BLOOD TRANSFUSION; BLOOD TRANSFUSION REACTION; CANADA; CLINICAL EFFECTIVENESS; DISEASE SURVEILLANCE; HEMATOLOGICAL PARAMETERS; HUMAN; MEDICAL INFORMATION SYSTEM; PRACTICE GUIDELINE; PRODUCT SAFETY; REVIEW; TRANSFUSION RELATED ACUTE LUNG INJURY; TRANSFUSION TRANSMITTED INJURY SURVEILLANCE SYSTEM;

ACUTE LUNG INJURY; BLOOD TRANSFUSION; DRUG CONTAMINATION; FEMALE; HEALTH CARE SURVEYS; HUMANS; MALE; NATIONAL HEALTH PROGRAMS; PILOT PROJECTS; PRACTICE GUIDELINES AS TOPIC; QUEBEC; SAFETY; TIME FACTORS;

EID: 84860432140     PISSN: 14730502     EISSN: 18781683     Source Type: Journal    
DOI: 10.1016/j.transci.2012.03.024     Document Type: Review

References (12)

1. The European Parliament and the Council of the European Union. Directive 2002/98/EC of the European Parliament and of the Council of 27 January 2003 setting standards of quality and safety for the collection, testing, processing, storage and distribution of human blood and blood components and amending Directive 2001/83/EC. Official Journal of the European Union 1995;OJ L 33(8.2.2003):30.
2. Stainsby D., Jones H., Asher D., Atterbury C., Boncinelli A., Brant L., et al. Serious hazards of transfusion: a decade of hemovigilance in the UK. Transfus Med Rev 2006, 20(4):273-282.
3. Faber J.-C. Haemovigilance in Europe: the European haemovigilance network. Transfus Clin Biol 2001, 8(3):285-290.
4. Faber J.-C. Worldwide overview of existing haemovigilance systems. Transf Apheres Sci 2004, 31:99-110.
5. Robillard P., Nawej K.I., Jochem K. The Quebec hemovigilance system: description and results from the first two years. Transf Apheres Sci 2004, 31(2):111-122.
6. Public Health Agency of Canada. Transfusion Transmitted Injuries Surveillance System. Report No. 2002-2003. Authority of the Minister of Health, Ottawa, Ontario; 2003. 1pp.
7. de Vries R.R., Faber J.C., Strengers P.F. Haemovigilance: an effective tool for improving transfusion practice. Vox Sang 2011, 100(1):60-67.
8. Robillard P, Nawej KI, Chapdelaine A. Incident/accident transfusion reported to the system haemovigilance Quebec in 2007.
9. Robillard P, Brottet E, Nawej KI. Positive impact of online inter-hospital consultation of transfusion history on incidence of red cell ABO mistransfusions, acute and delayed hemolytic transfusion reactions. Transfusion 2006;46(Suppl. 9S):13A-14A [Ref Type: Abstract].
10. Robillard P., Delage G., Nawej K.I., Goldman M. Use of hemovigilance data to evaluate the effectiveness of diversion and bacterial detection. Transfusion 2011, 7.
11. Chapman C.E., Stainsby D., Jones H., Love E., Massey E., Win N., et al. Ten years of hemovigilance reports of transfusion-related acute lung injury in the United Kingdom and the impact of preferential use of male donor plasma. Transfusion 2009, 49(3):440-452.
12. Wiersum-Osselton J.C., Middelburg R.A., Beckers E.A., Van Tilborgh A.J., Zijlker-Jansen P.Y., Brand A., et al. Male-only fresh-frozen plasma for transfusion-related acute lung injury prevention: before-and-after comparative cohort study. Transfusion 2010, 6.